Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. CAPR
CAPR logo

CAPR

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

CAPR News

Caprock Mining Closes $600,000 Financing Through Flow-Through Shares

20h agoYahoo Finance

FDA Reversal Sparks Biotech Comeback for UniQure and Peers

2d agoseekingalpha

Capricor Sues Nippon Shinyaku Over DMD Therapy Distribution

3d agostocktwits

Capricor Therapeutics to Participate in Upcoming Investor Conferences

Jun 08 2026Newsfilter

Capricor Therapeutics Q1 2026 Earnings Call Insights

May 13 2026seekingalpha

Capricor Therapeutics to Announce Q1 Earnings on May 12

May 12 2026seekingalpha

Capricor Executive Exercises Stock Options in $793K Transaction

May 10 2026Fool

Krasney Sells Shares for Diversification Under 10b5-1 Plan

May 10 2026NASDAQ.COM

Capricor Sues Nippon Shinyaku Over Pricing Flaw

May 08 2026seekingalpha

Middle East Tensions Ease as Investors Await Jobs Data

May 08 2026stocktwits

Capricor Sues NS Pharma Over Deramiocel Launch Issues

May 08 2026stocktwits

FDA Leadership Contender Sparks Market Interest

May 04 2026stocktwits

Capricor's Biologics Application Under FDA Review

Apr 22 2026stocktwits

Capricor Presents Phase 3 Data for DMD Therapy Deramiocel

Apr 22 2026Newsfilter

Capricor's Former Executive Considered for FDA Biologics Chief

Apr 14 2026stocktwits

Analysts Bullish on Capricor's Treatment Prospects

Mar 13 2026stocktwits